title: Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study.
abstract: Previous studies of blood pressure and mortality in haemodialysis have yielded mixed results, perhaps due to confounding by comorbid conditions. We hypothesized that after improved accounting for confounding factors, higher systolic blood pressure (SBP) would be associated with higher all-cause mortality. We conducted a secondary analysis of data from the haemodialysis study, a randomized trial in prevalent haemodialysis patients. We used three proportional hazard models to determine the relative hazard at different levels of SBP: (1) Model-BL used baseline SBP; (2) Model-TV used SBP as a time-varying variable; and (3) Model-TV-Lag added a 3-month lag to Model-TV to de-emphasize changes in SBP associated with acute illness. In all the models, pre-dialysis SBP <120 mm Hg was associated with a higher risk of mortality compared with the referent group (140-159 mm Hg); higher pre-dialysis SBP was not associated with higher risk of mortality. In conclusion, we observed a robust association between lower pre-dialysis SBP and higher risk for all-cause and cardiovascular mortality in a well-characterized cohort of prevalent haemodialysis patients. Randomized clinical trials are needed to define optimal blood pressure targets in the haemodialysis population.
authors.affiliation: Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA. tichang@stanford.edu
authors.forename: T I
authors.initials: TI
authors.lastname: Chang
authors.forename: G D
authors.initials: GD
authors.lastname: Friedman
authors.forename: A K
authors.initials: AK
authors.lastname: Cheung
authors.forename: T
authors.initials: T
authors.lastname: Greene
authors.forename: M
authors.initials: M
authors.lastname: Desai
authors.forename: G M
authors.initials: GM
authors.lastname: Chertow
mesh_terms: D000704:Analysis of Variance; D001794:Blood Pressure; D001795:Blood Pressure Determination; D015897:Comorbidity; D015986:Confounding Factors, Epidemiologic; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D016016:Proportional Hazards Models; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis / Q000401:mortality*; D012307:Risk Factors; D013997:Time Factors
references.citation: Kidney Int. 1998 Aug;54(2):561-9
references.pmid: 9690224
references.citation: Hypertension. 2010 Mar;55(3):762-8
references.pmid: 20083728
references.citation: JAMA. 2002 Mar 27;287(12):1548-55
references.pmid: 11911757
references.citation: JAMA. 2003 May 21;289(19):2560-72
references.pmid: 12748199
references.citation: Kidney Int. 2000 Nov;58(5):2147-54
references.pmid: 11044236
references.citation: Lancet. 2009 Mar 21;373(9668):1009-15
references.pmid: 19249092
references.citation: Kidney Int. 2005 Jan;67(1):1-13
references.pmid: 15610223
references.citation: Am J Kidney Dis. 2006 Oct;48(4):606-15
references.pmid: 16997057
references.citation: N Engl J Med. 2001 Nov 1;345(18):1291-7
references.pmid: 11794147
references.citation: N Engl J Med. 2002 Dec 19;347(25):2010-9
references.pmid: 12490682
references.citation: Clin J Am Soc Nephrol. 2009 May;4(5):914-20
references.pmid: 19357245
references.citation: Nephrology (Carlton). 2009 Apr;14(3):283-90
references.pmid: 19444959
references.citation: Kidney Int. 2002 Feb;61(2):717-26
references.pmid: 11849415
references.citation: Am J Kidney Dis. 2005 Apr;45(4 Suppl 3):S1-153
references.pmid: 15806502
references.citation: Heart. 2009 Jan;95(1):56-62
references.pmid: 18653573
references.citation: Kidney Int. 2002 Nov;62(5):1784-90
references.pmid: 12371980
references.citation: Am J Kidney Dis. 2002 Jun;39(6):1226-30
references.pmid: 12046035
references.citation: BMJ. 1989 Jun 10;298(6687):1552-6
references.pmid: 2503114
references.citation: Kidney Int. 2008 Mar;73(6):759-64
references.pmid: 18160959
references.citation: Am J Kidney Dis. 2002 Feb;39(2):227-44
references.pmid: 11840363
references.citation: Hypertension. 2009 May;53(5):860-6
references.pmid: 19273737
references.citation: Lancet. 2002 Dec 14;360(9349):1903-13
references.pmid: 12493255
references.citation: Kidney Int. 2001 Oct;60(4):1498-510
references.pmid: 11576365
references.citation: Control Clin Trials. 2000 Oct;21(5):502-25
references.pmid: 11018567
references.citation: J Am Soc Nephrol. 2006 Feb;17(2):513-20
references.pmid: 16396968
references.citation: Kidney Int. 1996 May;49(5):1379-85
references.pmid: 8731103
references.citation: Clin J Am Soc Nephrol. 2006 May;1(3):389-98
references.pmid: 17699236
references.citation: Am J Kidney Dis. 1999 Mar;33(3):507-17
references.pmid: 10070915
references.citation: Am J Kidney Dis. 2002 Jan;39(1):146-53
references.pmid: 11774113